BLUE THERAPEUTICS, INC.
Cambridge, MA · Biotech · Private
Blue181, a selective CNS agonist molecule for pain relief with reduced opioid side effects
bluetherapeutics.com →- Grants
- $7.0M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of a non-addictive analgesic targeting opioid receptor heteromers. | $746,689 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a non-addictive analgesic targeting opioid receptor heteromers. | $655,681 | |
| Federal grant | Department of Health and Human Services · Phase I · Identification of lead chemical scaffolds targeting opioid receptor heteromers. | $249,685 | |
| Federal grant | Department of Health and Human Services · Phase I · Blue Therapeutics I-Corps Application | $304,685 | |
| Federal grant | Department of Health and Human Services · Phase I · Blue Therapeutics I-Corps Application | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Completion of IND-package for a novel, non-narcotic painkiller | $3,250,676 | |
| Federal grant | Department of Health and Human Services · Phase II · Completion of IND-package for a novel, non-narcotic painkiller | $1,776,585 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2128 | CMTX BIOTECH INC | — | $500K |
| 2129 | ProMIS Neurosciences Inc. | — | $39M |
| 2130 | CASI Pharmaceuticals, Inc. | — | $35M |
| 2131 | BLUE THERAPEUTICS, INC. | — | — |
| 2132 | ProteoPrinceps, LLC | — | — |
| 2133 | Rebiotix Inc. | — | $29M |
| 2134 | Mahzi Therapeutics Inc. | — | $27M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Treating Acute Or Chronic Paingranted
- Methods Of Treating Irritable Bowel Syndromeapplication
- Methods Of Treating Irritable Bowel Syndromeapplication
- Methods Of Treating Acute Or Chronic Painapplication
- Methods Of Treating Acute Or Chronic Painapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.